BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,082,508 | -35.0% | 28,600 | -42.8% | 0.05% | -34.7% |
| Q1 2024 | $4,743,000 | -28.2% | 50,000 | -30.2% | 0.07% | -18.2% |
| Q4 2023 | $6,607,520 | +163.1% | 71,634 | +43.3% | 0.09% | +131.6% |
| Q3 2023 | $2,511,000 | -32.8% | 50,000 | -32.4% | 0.04% | -25.5% |
| Q2 2022 | $3,738,000 | -30.2% | 74,000 | +48.0% | 0.05% | -15.0% |
| Q4 2021 | $5,354,000 | -4.1% | 50,000 | -7.9% | 0.06% | -6.2% |
| Q3 2021 | $5,581,000 | +334.0% | 54,291 | +146.8% | 0.06% | -12.3% |
| Q1 2020 | $1,286,000 | -93.4% | 22,000 | -91.8% | 0.07% | -92.9% |
| Q3 2019 | $19,624,000 | +65.2% | 267,100 | +112.2% | 1.02% | +70.7% |
| Q2 2019 | $11,876,000 | +724.1% | 125,900 | +599.4% | 0.60% | +657.0% |
| Q1 2019 | $1,441,000 | – | 18,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |